Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L

Citations of this article
Mendeley users who have this article in their library.


RNase L helps mediate the antiviral state induced by type I interferons (IFNαβ). Although herpes simplex virus (HSV) encodes inhibitors of the IFNαβ-induced antiviral response, the IFNαβ system serves the body as a first line of defense against HSV. We investigated whether RNase L limits HSV-2 replication and virulence. RNaseL-/- and wild-type C57BL/6 mice were infected intravaginally with HSV-2 strain 333. Although initial replication in the genital epithelium was similar, mice lacking RNase L developed less severe genital and neurologic disease than wild-type mice, survived longer, and contained lower viral titers in the nervous system. CD4+ T cell infiltration into the genital tract and spinal cord of RNase L-/- mice was reduced, suggesting that a restricted inflammatory response may account for reduction in disease. Thus, RNase L does not play a significant role in control of HSV-2 infection in vivo; instead, RNase L may regulate aspects of the inflammatory response that contribute to disease. © 2006 Elsevier Inc. All rights reserved.




Duerst, R. J., & Morrison, L. A. (2007). Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L. Virology, 360(2), 322–328. https://doi.org/10.1016/j.virol.2006.10.042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free